News List

GE introduces healthcare technology company to revolutionize blood collection


Drawbridge Health is developing proprietary technology designed to integrate draw, collection and sample stabilization into a single device.

By Team ABLE

GE has recently introduced Drawbridge Health, a privately-held healthcare technology company focused on enabling personal diagnostic testing — anytime, anywhere.

Drawbridge Health is developing proprietary technology designed to integrate draw, collection and sample stabilization into a single device.

Healthcare providers will be able to deliver a superior patient experience, eliminating the need for phlebotomy and travel to blood draw centers. This integrated technology is also being developed to support room temperature shipping and streamlined downstream processing, ensuring reliable, accurate results. Through this integration of engineering and proprietary chemistry, Drawbridge Health is developing a people-friendly system for drawing and stabilizing blood samples.

GE has said in its press release that the Drawbridge solution is being designed to offer a way for healthcare providers and diagnostic testing companies to better engage their patient-consumers and help enable them to manage their own health — driving a shift from reacting to tracking.

By introducing a simple, comfortable blood draw solution, Drawbridge Health can alter the market for patients and healthcare providers by broadening the availability and access for molecular tests for a variety of diseases, as well as providing a convenient way to monitor overall health, therapy response and disease progression.

Drawbridge Health is led by Lee McCracken, Chief Executive Officer, along with Board Members, Risa Stack, General Manager of New Business Creation at GE Ventures, and Ger Brophy, General Manager of Cell Therapy at GE Healthcare Life Sciences.